Nurix Therapeutics, Inc. (NRIX)
19.04
+0.11
(+0.58%)
USD |
NASDAQ |
Jan 14, 16:00
19.02
-0.02
(-0.08%)
After-Hours: 20:00
Nurix Therapeutics EPS Diluted (Quarterly): -1.027 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| GT Biopharma, Inc. | -0.8268 |
| Incyte Corp. | 2.106 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -86.42M |
| Revenue (Quarterly) | 7.894M |
| Total Expenses (Quarterly) | 94.32M |
| Enterprise Value | 1.092B |
| Gross Profit Margin (Quarterly) | 36.66% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -15.58% |
| Normalized Earnings Yield | -15.58 |